Novel combination of serum microRNA for detecting breast cancer in the early stage

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier

(2015) Naoomi Tominaga et al.   Nature Communications

MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers

(2015) Motohiro Kojima et al.   PLoS One

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection

(2015) Jie Shen et al.   Oncotarget

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers

(2014) Silvia Zearo et al.   BMC CANCER

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

(2014) Marek Sochor et al.   BMC CANCER

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study

(2014) Annette R. Kodahl et al.   Molecular Oncology

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells

(2014) M. Ono et al.   Science Signaling

Identification of Circulating MicroRNA Signatures for Breast Cancer Detection

(2013) M. Chan et al.   CLINICAL CANCER RESEARCH

Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers

(2013) Fermín Mar-Aguilar et al.   DISEASE MARKERS

Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

(2013) Enders K. O. Ng et al.   PLoS One

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer

(2013) Katarina Cuk et al.   PLoS One

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

(2012) Mayu Yunokawa et al.   CANCER SCIENCE

Circulating microRNAs in plasma as early detection markers for breast cancer

(2012) Katarina Cuk et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

(2012) Haiyan Si et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

(2012) Ioannis S. Vlachos et al.   NUCLEIC ACIDS RESEARCH

Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer

(2012) Yu Sun et al.   PLoS One

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

(2011) Eun-Jung Jung et al.   CANCER

Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer

(2010) S. Asaga et al.   CLINICAL CHEMISTRY

Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease

(2010) H. M. Heneghan et al.   ONCOLOGIST

Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells

(2010) Lucy Pigati et al.   PLoS One

Investigating the Efficacy of Nonlinear Dimensionality Reduction Schemes in Classifying Gene and Protein Expression Studies

(2008) G. Lee et al.   IEEE-ACM Transactions on Computational Biology and Bioinformatics